[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CN103275085B - Quinazoline and quinazolinone compound, its synthesis method and application - Google Patents

Quinazoline and quinazolinone compound, its synthesis method and application Download PDF

Info

Publication number
CN103275085B
CN103275085B CN201310224222.7A CN201310224222A CN103275085B CN 103275085 B CN103275085 B CN 103275085B CN 201310224222 A CN201310224222 A CN 201310224222A CN 103275085 B CN103275085 B CN 103275085B
Authority
CN
China
Prior art keywords
compound
formula
reaction
quinazolinones
quinazo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310224222.7A
Other languages
Chinese (zh)
Other versions
CN103275085A (en
Inventor
陈久喜
吴华悦
刘妙昌
高文霞
黄小波
陈锡安
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wenzhou University
Original Assignee
Wenzhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wenzhou University filed Critical Wenzhou University
Priority to CN201310224222.7A priority Critical patent/CN103275085B/en
Publication of CN103275085A publication Critical patent/CN103275085A/en
Application granted granted Critical
Publication of CN103275085B publication Critical patent/CN103275085B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明涉及一种喹唑啉并喹唑啉酮化合物、其合成方法和用途。所述合成方法是以铜化合物作为催化剂,由二氢喹唑啉酮和脒类化合物进行反应而一步制得,反应条件温和、产品收率高、后处理简单。此外,出人意料地发现所述喹唑啉并喹唑啉酮化合物具有显著的荧光强度改变特性,可用于荧光传感等应用领域,具有广阔的应用前景和研究价值。

The invention relates to a quinazolinoquinazolinone compound, its synthesis method and application. The synthesis method uses a copper compound as a catalyst to react dihydroquinazolinone and amidine compounds in one step. The reaction conditions are mild, the product yield is high, and the aftertreatment is simple. In addition, it was unexpectedly found that the quinazolinoquinazolinone compound has significant fluorescence intensity changing characteristics, can be used in application fields such as fluorescence sensing, and has broad application prospects and research value.

Description

一种喹唑啉并喹唑啉酮化合物及其合成方法和用途A kind of quinazolinoquinazolinone compound and its synthesis method and application

技术领域 technical field

本发明涉及一种含氮杂环类化合物,特别地涉及一种喹唑啉并喹唑啉酮化合物及其合成方法和用途,属于有机化学领域。 The invention relates to a nitrogen-containing heterocyclic compound, in particular to a quinazolinoquinazolinone compound and its synthesis method and application, belonging to the field of organic chemistry.

背景技术 Background technique

多环含氮杂环化合物广泛地存在于自然界中,其中的一些因具有一定的生物活性而被用于药物研究,例如早已发现以喹唑啉酮为骨架的多环化合物存在于可作为药物的多种天然产物的核心结构骨架中,例如存在于脱氧鸭嘴花酮碱(deoxyvasicinone)、骆驼宁碱A(Luotonin A)、Circumdatins、吴茱萸次碱(Rutaecarpine)和色胺酮(Tryptanthrin)等活性化合物中。由于多环的喹唑啉酮化合物具有多种药物活性,如抗肿瘤、抗细菌、抗真菌、抗抑郁、抗炎、抗风湿、抗高血压、抗痉挛、抗疟疾、抗感染和止痛等诸多药理活性而受到了药物研发人员的高度关注和重视,并开发了多种喹唑啉酮类化合物及其化学合成方法。 Polycyclic nitrogen-containing heterocyclic compounds widely exist in nature, and some of them are used in drug research because of their certain biological activities. For example, it has been found that polycyclic compounds with quinazolinone as the skeleton exist in the In the core structure skeleton of a variety of natural products, such as active compounds such as deoxyvasicinone, Luotonin A, Circumdatins, Rutaecarpine and Tryptanthrin middle. Because polycyclic quinazolinone compounds have a variety of pharmaceutical activities, such as anti-tumor, anti-bacterial, anti-fungal, anti-depressant, anti-inflammatory, anti-rheumatic, anti-hypertensive, anti-spasmodic, anti-malarial, anti-infection and analgesic, etc. Pharmacological activity has been highly concerned and valued by drug researchers, and a variety of quinazolinone compounds and their chemical synthesis methods have been developed.

李书义(″喹唑啉酮衍生物的合成研究″,西北大学硕士论文,2009年)公开了一种制备喹唑啉酮衍生物的有机合成方法,所述方法是利用微波辅助合成,以取代苯甲酸与甲酰胺进行反应,以及使用1,4-丁炔二醇、L-谷氨酰胺和靛红酸酐进行反应,而得到了多个喹唑啉酮衍生物。 Li Shuyi ("Synthetic Research on Quinazolinone Derivatives", Master Thesis of Northwest University, 2009) discloses an organic synthesis method for preparing quinazolinone derivatives. The method is to use microwave-assisted synthesis to replace benzene Reaction of formic acid with formamide, as well as with 1,4-butynediol, L-glutamine and isatoic anhydride, yields a number of quinazolinone derivatives.

CN1845908A公开了一类5-取代喹唑啉酮及其制备方法,所述喹唑啉酮可用作α-1A/B肾上腺素能受体拮抗剂。 CN1845908A discloses a class of 5-substituted quinazolinones and a preparation method thereof. The quinazolinones can be used as alpha-1A/B adrenergic receptor antagonists.

CN101415688A公开了一类喹唑啉酮衍生物,其具有B-RAF抑制活性,可用于人类的抗癌治疗中。 CN101415688A discloses a class of quinazolinone derivatives, which have B-RAF inhibitory activity and can be used in human anticancer treatment.

CN1628104A公开一类喹唑啉酮衍生物,其可作为CB激动剂。 CN1628104A discloses a class of quinazolinone derivatives, which can be used as CB agonists.

CN1538966A公开了一类喹唑啉酮衍生物,所述衍生物具有M3选择性毒蕈碱受体拮抗作用和节律性膀胱收缩频度抑制作用,可用来治疗尿频或尿失禁。 CN1538966A discloses a class of quinazolinone derivatives, which have M3 selective muscarinic receptor antagonism and rhythmic bladder contraction frequency inhibition, and can be used to treat urinary frequency or urinary incontinence.

CN101429166A公开了一种喹唑啉酮衍生物及其制备方法和用 途,其具有比西地那非更强的PDES抑制活性,且相对于分布在视网膜的PED6具有更高的选择性,从而在临床上表现出更佳的安全性和有效性。 CN101429166A discloses a quinazolinone derivative and its preparation method and application, which has a stronger PDES inhibitory activity than sildenafil, and has higher selectivity relative to PED6 distributed in the retina, thereby in Clinically demonstrated better safety and efficacy.

CN1683844A公开了一种4-喹唑啉酮衍生物及其在抗肿瘤药物中的应用,所述衍生物具有抗肿瘤活性。 CN1683844A discloses a 4-quinazolinone derivative and its application in antitumor drugs, the derivative has antitumor activity.

CN1856485A公开一种苯并咪唑酮和喹唑啉酮衍生物,所述化合物可作为人类ORL1受体的激动剂,从而可治疗涉及ORL1受体的疾病。 CN1856485A discloses a derivative of benzimidazolone and quinazolinone, said compound can be used as an agonist of human ORL1 receptor, so as to treat diseases involving ORL1 receptor.

CN1845924A公开了一种芳基胺取代的喹唑啉酮化合物,所述化合物可治疗与作α-1A/B肾上腺素受体活性有关的疾病。 CN1845924A discloses a quinazolinone compound substituted by arylamine, which can treat diseases related to α-1A/B adrenoceptor activity.

CN1708306A公开了一种喹唑啉酮化合物,其可作为钙阻滞剂,从而起到钙受体拮抗剂的作用。 CN1708306A discloses a quinazolinone compound, which can be used as a calcium blocker, thereby acting as a calcium receptor antagonist.

CN1980899A公开了一种喹唑啉酮衍生物,所述衍生物可作为PARP抑制剂,可用来治疗多种涉及PARP的疾病。 CN1980899A discloses a quinazolinone derivative, which can be used as a PARP inhibitor and can be used to treat various diseases involving PARP.

如上所述,虽然现有技术中公开了制备喹唑啉酮的多种方法,但同时含有喹唑啉酮和喹唑啉稠合骨架的化合物却鲜有报道,更遑论其制备方法路线与方法了。 As mentioned above, although a variety of methods for the preparation of quinazolinones have been disclosed in the prior art, there are few reports on compounds containing quinazolinones and quinazoline fused skeletons at the same time, let alone their preparation method routes and methods. up.

此外,迄今为止,所有涉及喹唑啉酮的研究均集中在其药物活性性能上,对于治疗机理、活性等进行了大量的研究,却从未涉及过除药物活性外的其它用途研究。 In addition, so far, all studies involving quinazolinones have focused on their pharmaceutical activity, and a large number of studies have been carried out on the therapeutic mechanism and activity, but have never involved research on other uses other than pharmaceutical activity.

因此,寻找其新的用途,并在该新用途的前提下探寻新的该类化合物,以及其全新的制备方法是目前存在的重点和难点课题,也是本发明得以完成和实现的出发点。 Therefore, finding its new use, and exploring new compounds of this type under the premise of the new use, and its brand-new preparation method are the key and difficult issues that exist at present, and are also the starting point for the completion and realization of the present invention.

发明内容 Contents of the invention

有鉴于此,为了寻求新的喹唑啉并喹唑啉酮化合物,其制备方法及其新的用途,本发明人进行了深入研究,在付出了大量的创造性劳动后,从而完成了本发明。 In view of this, in order to seek new quinazolinoquinazolinone compounds, their preparation methods and their new applications, the inventors conducted in-depth research, and completed the present invention after paying a lot of creative work.

具体而言,本发明的技术方案和内容涉及三个方面:喹唑啉并喹唑啉酮化合物、其制备方法及其新的用途。 Specifically, the technical scheme and content of the present invention relate to three aspects: quinazolinoquinazolinone compounds, their preparation methods and their new uses.

第一方面,本发明涉及一种喹唑啉并喹唑啉酮化合物,其结构式如下式(I)所示。 In the first aspect, the present invention relates to a quinazolinoquinazolinone compound, the structural formula of which is shown in the following formula (I).

其中: in:

R1-R4各自相同或不同,且独立地选自H、C1-C6烷基、卤素、C1-C6烷氧基; R 1 -R 4 are each the same or different, and are independently selected from H, C 1 -C 6 alkyl, halogen, C1-C6 alkoxy;

R选自C1-C6烷基、C1-C6烷氧基、C3-C6环烷基; R is selected from C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 3 -C 6 cycloalkyl;

条件是当R为甲基时,R1-R4不同时为H。 Provided that when R is methyl, R 1 -R 4 are not H at the same time.

在本发明中,除非另有规定,自始至终,C1-C6烷基的含义是指具有1-6个碳原子的直链或支链烷基,其包括了C1烷基、C2烷基、C3烷基、C4烷基、C5烷基或C6烷基,非限定性地例如可为甲基、乙基、正丙基、异丙基、正丁基、仲丁基、异丁基、叔丁基、正戊基、异戊基或正己基等。 In the present invention, unless otherwise specified, throughout, the meaning of C 1 -C 6 alkyl refers to straight chain or branched chain alkyl having 1-6 carbon atoms, which includes C 1 alkyl, C 2 alkane C 3 alkyl, C 4 alkyl, C 5 alkyl or C 6 alkyl, non-limiting examples may be methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl , isobutyl, tert-butyl, n-pentyl, isopentyl or n-hexyl, etc.

在本发明中,除非另有规定,自始至终,C1-C6烷氧基是指上述定义的″C1-C6烷基″与O原子相连后的基团。 In the present invention, unless otherwise specified, throughout, C 1 -C 6 alkoxy refers to a group in which the "C 1 -C 6 alkyl" defined above is linked to an O atom.

在本发明中,除非另有规定,自始至终,C3-C6环烷基的含义是指具有3-6个碳原子的环状烷基,其包括了C3环烷基、C4环烷基、C5环烷基或C6环烷基,非限定地例如可为环丙基、环丁基、环戊基或环己基。 In the present invention, unless otherwise specified, throughout, the meaning of C 3 -C 6 cycloalkyl refers to a cyclic alkyl group with 3-6 carbon atoms, which includes C 3 cycloalkyl, C 4 cycloalkane Group, C 5 cycloalkyl or C 6 cycloalkyl, non-limiting examples may be cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl.

在本发明中,除非另有规定,自始至终,卤素的含义是指卤族元素,非限定地例如可为F、Cl、Br或I。 In the present invention, unless otherwise specified, throughout, the meaning of halogen refers to halogen elements, such as F, Cl, Br or I without limitation.

作为一种优选实施方式,R为C2-C6烷基或C3-C6环烷基,优选为乙基或环丙基。 As a preferred embodiment, R is C 2 -C 6 alkyl or C 3 -C 6 cycloalkyl, preferably ethyl or cyclopropyl.

作为一种优选实施方式,R4为H。 As a preferred embodiment, R4 is H.

第二方面,本发明涉及式(I)的喹唑啉并喹唑啉酮化合物的合成方法。 In a second aspect, the present invention relates to a synthesis method of a quinazolinoquinazolinone compound of formula (I).

所述方法包括在在铜源催化剂和碱存在下,于有机溶剂中使式(II)与(III)反应而得到式(I)化合物。 The method comprises reacting formula (II) with (III) in an organic solvent in the presence of a copper source catalyst and a base to obtain a compound of formula (I).

其中,R1-R4、R的定义如上所述。 Wherein, the definitions of R 1 -R 4 and R are as above.

X为卤素,例如可为F、Cl、Br或I。 X is halogen and can be F, Cl, Br or I, for example.

在本发明的所述合成方法中,所述铜源催化剂为无机铜、有机铜或两者的混合物。 In the synthesis method of the present invention, the copper source catalyst is inorganic copper, organic copper or a mixture of both.

所述无机铜选自卤化铜或卤化亚铜,非限定性地例如可为CuI、CuBr、CuCl、CuCl2、CuBr2、CuI2中的任意一种或多种,即所述铜源催化剂可为这些具体物质中的任意一种或多种。 The inorganic copper is selected from copper halide or cuprous halide, non-limitatively, for example, it can be any one or more of CuI, CuBr, CuCl, CuCl2 , CuBr2 , CuI2 , that is, the copper source catalyst can be Any one or more of these specific substances.

所述有机铜选自乙酸铜[Cu(OAc)2]、乙酰丙酮铜[Cu(acac)2]、Cu(PPh3)2NO3、乙基乙酰乙酸铜(II)、六氟乙酰丙酮铜中的任何一种或多种,即所述铜源催化剂可为这些具体物质中的任意一种或多种。 The organic copper is selected from copper acetate [Cu(OAc) 2 ], copper acetylacetonate [Cu(acac) 2 ], Cu(PPh 3 ) 2 NO 3 , copper(II) ethylacetoacetate, copper hexafluoroacetylacetonate Any one or more of them, that is, the copper source catalyst can be any one or more of these specific substances.

所述铜源催化剂优选为Cu(acac)2、六氟乙酰丙酮铜、Cu(PPh3)2NO3,最优选为Cu(acac)2The copper source catalyst is preferably Cu(acac) 2 , copper hexafluoroacetylacetonate, Cu(PPh 3 ) 2 NO 3 , most preferably Cu(acac) 2 .

在本发明的所述合成方法中,所述碱例如可为碱金属的碳酸盐、磷酸盐、氢氧化物、醇盐中的任何一种或多种。 In the synthesis method of the present invention, the base can be, for example, any one or more of alkali metal carbonates, phosphates, hydroxides, and alkoxides.

作为例举,所述碱例如可为碳酸钾、磷酸钾、碳酸锂、氢氧化锂、碳酸铯中的任何一种或多种。 As an example, the base may be any one or more of potassium carbonate, potassium phosphate, lithium carbonate, lithium hydroxide, and cesium carbonate.

所述碱优选为磷酸钾、碳酸钾、氢氧化锂或碳酸铯,最优选为碳酸铯。 The base is preferably potassium phosphate, potassium carbonate, lithium hydroxide or cesium carbonate, most preferably cesium carbonate.

在本发明的所述合成方法中,式(II)与(III)进行反应时的反应溶剂并没有特别的限定,可为有机合成领域中所使用的任何常规有机溶剂,非限定性地例如可为苯、甲苯、二甲苯、氯苯、丙酮、1,4-二氧六环、1,6-二氧六环、四氢呋喃(THF)、2-甲基四氢呋喃、N,N-二甲基甲酰胺(DMF)、二甲基亚砜(DMSO)、二氯甲烷、三氯甲烷、四氯化碳、二氯乙烷、正己烷、乙醚、甲醇、乙醇、正丙醇、异丙醇、丁醇、戊醇、己醇等中的一种或多种。 In the synthesis method of the present invention, the reaction solvent when the formula (II) reacts with (III) is not particularly limited, and can be any conventional organic solvent used in the field of organic synthesis, non-limitingly, for example, Benzene, toluene, xylene, chlorobenzene, acetone, 1,4-dioxane, 1,6-dioxane, tetrahydrofuran (THF), 2-methyltetrahydrofuran, N,N-dimethylmethane Amide (DMF), Dimethyl Sulfoxide (DMSO), Dichloromethane, Chloroform, Carbon Tetrachloride, Dichloroethane, n-Hexane, Diethyl Ether, Methanol, Ethanol, n-Propanol, Isopropanol, Butyl One or more of alcohol, pentanol, hexanol, etc.

在本发明的所述合成方法中,可对所述式(II)与(III)化合物的摩尔比进行合适的选择,例如摩尔比可为1∶1-4,该范围包括了其中的任何子区间范围,如1∶1.4-3.6、1∶1.8-3.2或1∶2.2-2.8,也包括了其中的任何具体点值,示例性地例如可为1∶1、1∶1.5、1∶2、1∶2.5、1∶3、1∶3.5或1∶4。 In the synthesis method of the present invention, the molar ratio of the compounds of formula (II) and (III) can be properly selected, for example, the molar ratio can be 1:1-4, and this range includes any subgroups thereof. The interval range, such as 1:1.4-3.6, 1:1.8-3.2 or 1:2.2-2.8, also includes any specific point value, for example, it can be 1:1, 1:1.5, 1:2, 1:2.5, 1:3, 1:3.5 or 1:4.

所述式(II)与(III)化合物的摩尔比优选为1∶2-3,例如为1∶2、1∶2.5或1∶3。 The molar ratio of the compounds of formula (II) to (III) is preferably 1:2-3, for example 1:2, 1:2.5 or 1:3.

在本发明的所述合成方法中,所述催化剂的用量并没有特别的限定,例如所述式(II)化合物与铜源催化剂的摩尔比可为1∶0.02-0.2,例如可为1∶0.02、1∶0.05、1∶0.08、1∶0.11、1∶0.14、1∶0.17或1∶0.2。 In the synthesis method of the present invention, the amount of the catalyst is not particularly limited, for example, the molar ratio of the compound of formula (II) to the copper source catalyst can be 1:0.02-0.2, for example, it can be 1:0.02 , 1:0.05, 1:0.08, 1:0.11, 1:0.14, 1:0.17 or 1:0.2.

在本发明的所述合成方法中,式(III)化合物还可以为盐的形式,例如为盐酸盐、硫酸盐、硝酸盐、磷酸盐或磷酸氢盐的形式,即还可以使用上述式(III)化合物与盐酸、硫酸、硝酸、磷酸等无机酸成盐后得到的盐形式化合物。。 In the synthesis method of the present invention, the compound of formula (III) can also be in the form of a salt, for example, in the form of hydrochloride, sulfate, nitrate, phosphate or hydrogen phosphate, that is, the above formula ( III) Compounds in the form of salts obtained after the compound is salified with inorganic acids such as hydrochloric acid, sulfuric acid, nitric acid, and phosphoric acid. .

在本发明的所述合成方法中,可对所述式(II)化合物与碱的摩尔比进行合适的选择,例如摩尔比可为1∶2-6,该范围包括了其中的任何子区间范围,如1∶2.4-5.6、1∶2.8-5.2、1∶3.2-4.8或1∶3.6-4.4,也包括了其中的任何具体点值,示例性地例如可为1∶2、1∶2.5、1∶3、1∶3.5、1∶4、1∶4.5、1∶5、1∶5.5或1∶6。 In the synthesis method of the present invention, the molar ratio of the compound of formula (II) to the base can be properly selected, for example, the molar ratio can be 1:2-6, and this range includes any subrange range therein , such as 1:2.4-5.6, 1:2.8-5.2, 1:3.2-4.8 or 1:3.6-4.4, also includes any specific point value, for example, it can be 1:2, 1:2.5, 1:3, 1:3.5, 1:4, 1:4.5, 1:5, 1:5.5 or 1:6.

所述式(II)化合物与碱的摩尔比优选为1∶3-5,例如为1∶3、1∶3.5、1∶4、1∶4.5或1∶5。 The molar ratio of the compound of formula (II) to the base is preferably 1:3-5, for example 1:3, 1:3.5, 1:4, 1:4.5 or 1:5.

在本发明的所述合成方法中,反应温度为60-120℃,非限定性地例如可为60℃、70℃、80℃、90℃、100℃、110℃或120℃。 In the synthesis method of the present invention, the reaction temperature is 60-120°C, for example, non-limitingly, 60°C, 70°C, 80°C, 90°C, 100°C, 110°C or 120°C.

所述反应温度优选为80-100℃,例如为80℃、90℃或100℃。 The reaction temperature is preferably 80-100°C, such as 80°C, 90°C or 100°C.

在本发明的所述合成方法中,反应时间并无特别的限定,例如可通过液相色谱检测目的产物或原料的残留百分比而确定合适的反应时间,其通常为16-30小时,非限定性地例如为16小时、18小时、20小时、22小时、24小时、26小时、28小时或30小时。 In the synthesis method of the present invention, the reaction time is not particularly limited, for example, the appropriate reaction time can be determined by liquid chromatography to detect the residual percentage of the target product or raw material, which is usually 16-30 hours, non-limiting For example, 16 hours, 18 hours, 20 hours, 22 hours, 24 hours, 26 hours, 28 hours or 30 hours.

所述反应时间优选为20-26小时,例如为20小时、22小时、24小时或26小时。 The reaction time is preferably 20-26 hours, such as 20 hours, 22 hours, 24 hours or 26 hours.

在本发明的所述合成方法中,反应结束后的后处理可采用有机 合成领域中的任何公知的常规处理手段,例如结晶、重结晶、柱色谱提纯、萃取等中的任何一种处理手段或多种处理手段的组合。作为一种例举性后处理手段,例如可为:将反应结束后得到的混合物倾入有机介质如酯类、醚类或醇类化合物中,例如倾倒到乙酸乙酯中,然后顺次用饱和NaHCO3水溶液和盐水洗涤,水层用常规有机介质如乙酸乙酯、苯、氯仿或四氢呋喃等萃取后,合并有机层(即合并洗涤后的有机层和萃取得到的有机层),用无水NaHSO4或无水MgSO4干燥,负压蒸发除去溶剂,残留物通过快速柱色谱(洗脱液例如可为正己烷/乙酸乙酯)提纯,得到目标产物。 In the synthetic method of the present invention, the aftertreatment after the reaction can adopt any known conventional treatment means in the field of organic synthesis, such as any treatment means in crystallization, recrystallization, column chromatography purification, extraction, etc. or A combination of various treatments. As an exemplary post-treatment method, for example, the mixture obtained after the reaction is poured into an organic medium such as esters, ethers or alcohol compounds, such as poured into ethyl acetate, and then saturated with Wash with NaHCO3 aqueous solution and brine, extract the aqueous layer with a conventional organic medium such as ethyl acetate, benzene, chloroform or tetrahydrofuran, etc., combine the organic layers (that is, combine the washed organic layer and the organic layer obtained by extraction), and wash with anhydrous NaHSO 4 or dried over anhydrous MgSO 4 , evaporated under negative pressure to remove the solvent, and the residue was purified by flash column chromatography (for example, n-hexane/ethyl acetate as the eluent) to obtain the target product.

在本发明的所述合成方法中,本发明所述反应优选在惰性气体保护下进行,所述惰性气体例如可为氮气。 In the synthesis method of the present invention, the reaction of the present invention is preferably carried out under the protection of an inert gas, such as nitrogen.

在本发明的所述合成方法中,作为原料的式(II)化合物可使用现有技术中已知的化合物,或者按照如下的方法,由邻氨基苯甲酰胺与苯甲醛合成而得到: In the synthesis method of the present invention, the compound of formula (II) as raw material can use the compound known in the prior art, or according to the following method, synthesized by anthranilamide and benzaldehyde:

其中R1-R4、X的定义如上。 wherein R 1 -R 4 and X are as defined above.

作为一种示例性例举,式(II)化合物可如下制备:在反应瓶中加入1当量的上式1化合物、1.2当量的上式2化合物、1.2当量的柠檬酸和适量的溶剂如乙醇或醚类等,于回流温度和搅拌下反应12-24小时。反应结束后,用无水MgSO4或无水硫酸氢钠干燥,减压浓缩除去乙醇,残留物用300-400目硅胶柱层析色谱分离便可得到上述目标产物(II)。 As an example, the formula (II) compound can be prepared as follows: add 1 equivalent of the above formula 1 compound, 1.2 equivalents of the above formula 2 compound, 1.2 equivalents of citric acid and an appropriate amount of solvent such as ethanol or Ethers, etc., react at reflux temperature and stirring for 12-24 hours. After the reaction, dry with anhydrous MgSO 4 or anhydrous sodium bisulfate, concentrate under reduced pressure to remove ethanol, and separate the residue with 300-400 mesh silica gel column chromatography to obtain the above target product (II).

第三方面,本发明涉及式(I)的喹唑啉并喹唑啉酮化合物在金属离子的荧光传感领域中的用途,例如可用于金属离子的标记、显示、检测、荧光淬灭等,尤其是涉及所述化合物用作Fe3+的荧光探针的用途。。 In a third aspect, the present invention relates to the use of the quinazolinoquinazolinone compound of formula (I) in the field of fluorescence sensing of metal ions, for example, it can be used for labeling, displaying, detecting, fluorescence quenching, etc. of metal ions, In particular it relates to the use of said compounds as fluorescent probes for Fe 3+ . .

通过将本发明的喹唑啉并喹唑啉酮化合物浸入金属离子溶液中 一定时间后,抽滤、干燥后测量其固体荧光数据,发现其荧光强度在某些波长范围内有显著改变的特性,可将其用于多种具体的荧光传感领域,在工业应用上具有良好的应用前景和研究价值。 By immersing the quinazolinoquinazolinone compound of the present invention in the metal ion solution for a certain period of time, and then measuring its solid fluorescence data after suction filtration and drying, it is found that its fluorescence intensity has the characteristics of significant changes in certain wavelength ranges, It can be used in a variety of specific fluorescent sensing fields, and has good application prospects and research value in industrial applications.

综上所述,本发明通过使用式(II)和(III)化合物作为反应底物,通过铜源催化剂和碱的协同作用,而一步合成得到了新颖的喹唑啉并喹唑啉酮化合物类化合物,反应简单、操作简便、收率高,是一种喹唑啉并喹唑啉酮化合物的全新合成方法,为该类化合物的制备提供了新的合成路线,同时发现了该新颖化合物的药物应用之外的新用途,为该类化合物的拓展应用提供了研究与理论基础。 In summary, the present invention obtains novel quinazolinoquinazolinone compounds in one step through the use of compounds of formula (II) and (III) as reaction substrates, through the synergistic effect of copper source catalyst and base Compound, simple reaction, easy operation, high yield, is a new synthetic method of quinazolinoquinazolinone compound, provides a new synthetic route for the preparation of this type of compound, and discovered the drug of this novel compound The new uses other than the application provide a research and theoretical basis for the expanded application of this type of compound.

附图说明 Description of drawings

图1是本发明的所述喹唑啉并喹唑啉酮化合物与不同金属离子结合后相对于波长的荧光强度示意图。 Fig. 1 is a schematic diagram of the fluorescence intensity of the quinazolinoquinazolinone compound of the present invention combined with different metal ions relative to the wavelength.

具体实施方式 Detailed ways

下面通过具体的实施例对本发明进行详细说明,但这些例举性实施方式的用途和目的仅用来例举本发明,并非对本发明的实际保护范围构成任何形式的任何限定,更非将本发明的保护范围局限于此。 The present invention will be described in detail below through specific examples, but the use and purpose of these exemplary embodiments are only used to exemplify the present invention, and do not constitute any form of any limitation to the actual protection scope of the present invention, nor will the present invention The scope of protection is limited to this.

实施例1 Example 1

(A)化合物(II)的制备 (A) Preparation of compound (II)

在反应瓶中加入10mmol邻氨基苯甲酰胺1、12mmol2-溴苯甲醛2、12mmol柠檬酸和10ml乙醇,于80℃下回流和搅拌下反应16小时。反应结束后,用无水MgSO4干燥,减压浓缩除去乙醇,残留物用400目硅胶柱层析色谱分离得目标产物(II),产率为81.7%。 Add 10mmol of anthranilamide 1, 12mmol of 2-bromobenzaldehyde 2, 12mmol of citric acid and 10ml of ethanol into the reaction flask, and react under reflux and stirring at 80°C for 16 hours. After the reaction was finished, it was dried with anhydrous MgSO 4 , concentrated under reduced pressure to remove ethanol, and the residue was separated by 400-mesh silica gel column chromatography to obtain the target product (II), with a yield of 81.7%.

(B)化合物(I)的制备 (B) Preparation of compound (I)

在装配有搅拌器、温度计、加料口的反应容器中,加入50ml溶剂THF,然后加入上式化合物(II)、(III)、Cu(acac)2和Cs2CO3,使其摩尔比为1∶1∶0.02∶2,其中式(II)化合物为10mmol。氮气置换三次,然后在持续通入氮气的保护下,于60℃和搅拌下反应16小时。反应结束后,将混合物倾入乙酸乙酯中,顺次用饱和NaHCO3水溶液和盐水洗涤,在水层用乙酸乙酯萃取后,合并有机层(即合并洗涤后的有机层和萃取得到的有机层),用无水Na2SO4干燥,负压蒸发除去溶剂,残留物通过快速柱色谱(正己烷/乙酸乙酯)提纯,得到上式中的目标产物(I)。产率为96.8%,纯度为98.5%(HPLC)。 In a reaction vessel equipped with a stirrer, a thermometer, and a feeding port, add 50ml of solvent THF, and then add compounds of the above formula (II), (III), Cu(acac) 2 and Cs 2 CO 3 so that the molar ratio is 1 : 1: 0.02: 2, wherein the compound of formula (II) is 10 mmol. Nitrogen was replaced three times, and then reacted at 60° C. with stirring for 16 hours under the protection of continuous feeding of nitrogen. After the reaction was finished, the mixture was poured into ethyl acetate, washed with saturated NaHCO3 aqueous solution and brine successively, and after the aqueous layer was extracted with ethyl acetate, the organic layer was combined (that is, the organic layer after washing and the organic layer obtained by extraction were combined). layer), dried with anhydrous Na 2 SO 4 , evaporated under negative pressure to remove the solvent, and the residue was purified by flash column chromatography (n-hexane/ethyl acetate) to obtain the target product (I) in the above formula. Yield 96.8%, purity 98.5% (HPLC).

熔点:203-205℃。 Melting point: 203-205°C.

核磁共振:1H NMR(500MHz,DMSO-d6)δ0.94(t,J=7.4Hz,3H),2.26(dq,J=14.8Hz,7.4Hz,1H),2.59(dq,J=14.8Hz,7.4Hz,1H),6.18(d,J=1.4Hz,1H),7.21-7.18(m,2H),7.28-7.27(m,1H),7.40-7.37(m,1H),7.48-7.44(m,1H),7.66-7.60(m,2H),7.96-7.94(m,1H),8.72(s,1H); NMR: 1 H NMR (500MHz, DMSO-d 6 ) δ0.94(t, J=7.4Hz, 3H), 2.26(dq, J=14.8Hz, 7.4Hz, 1H), 2.59(dq, J=14.8 Hz, 7.4Hz, 1H), 6.18(d, J=1.4Hz, 1H), 7.21-7.18(m, 2H), 7.28-7.27(m, 1H), 7.40-7.37(m, 1H), 7.48-7.44 (m, 1H), 7.66-7.60(m, 2H), 7.96-7.94(m, 1H), 8.72(s, 1H);

13C NMR(125MHz,DMSO-d6)δ10.3,26.8,64.1,118.7,124.3,124.7,125.1,126.7,126.8,127.5,127.6,130.0,132.3,140.7,141.3,155.7,162.2。 13 C NMR (125 MHz, DMSO-d 6 ) δ 10.3, 26.8, 64.1, 118.7, 124.3, 124.7, 125.1, 126.7, 126.8, 127.5, 127.6, 130.0, 132.3, 140.7, 141.3, 155.7, 162.2.

实施例2 Example 2

(A)化合物(II)的制备 (A) Preparation of compound (II)

在反应瓶中加入10mmol2-氨基-5-甲基苯甲酰胺1、12mmol2-溴苯甲醛2、12mmol柠檬酸和10ml乙醇,于80℃下回流和搅拌下反应16小时。反应结束后,用无水MgSO4干燥,减压浓缩除去乙醇,残留物用350目硅胶柱层析色谱分离得目标产物(II),产率为86.3%。 Add 10mmol of 2-amino-5-methylbenzamide 1, 12mmol of 2-bromobenzaldehyde 2, 12mmol of citric acid and 10ml of ethanol into the reaction flask, and react under reflux and stirring at 80°C for 16 hours. After the reaction was finished, it was dried with anhydrous MgSO 4 , concentrated under reduced pressure to remove ethanol, and the residue was separated by 350-mesh silica gel column chromatography to obtain the target product (II), with a yield of 86.3%.

(B)化合物(I)的制备 (B) Preparation of compound (I)

在装配有搅拌器、温度计、加料口的反应容器中,加入50ml溶剂甲苯,然后加入上式化合物(II)、(III)、Cu(acac)2和Cs2CO3,使其摩尔比为1∶2∶0.05∶3,其中式(II)化合物为10mmol。氮气置换三次,然后在持续通入氮气的保护下,于80℃和搅拌下反应20小时。反应结束后,将混合物倾入乙酸乙酯中,顺次用饱和NaHCO3水溶液和盐水洗涤,在水层用乙酸乙酯萃取后,合并有机层(即合并洗涤后的有机层和萃取得到的有机层),用无水MgSO4干燥,负压蒸发除去溶剂,残留物通过快速柱色谱(正己烷/乙酸乙酯)提纯,得到上式中的目标产物(I)。产率为97.2%,纯度为99.1%(HPLC)。 In the reaction vessel equipped with stirrer, thermometer, feeding port, add 50ml solvent toluene, then add above formula compound (II), (III), Cu(acac) 2 and Cs 2 CO 3 , make its molar ratio be 1 :2:0.05:3, wherein the compound of formula (II) is 10 mmol. Nitrogen was replaced three times, and then reacted at 80° C. with stirring for 20 hours under the protection of continuous feeding of nitrogen. After the reaction was finished, the mixture was poured into ethyl acetate, washed with saturated NaHCO3 aqueous solution and brine successively, and after the aqueous layer was extracted with ethyl acetate, the organic layer was combined (that is, the organic layer after washing and the organic layer obtained by extraction were combined). layer), dried with anhydrous MgSO4 , evaporated under negative pressure to remove the solvent, and the residue was purified by flash column chromatography (n-hexane/ethyl acetate) to obtain the target product (I) in the above formula. Yield 97.2%, purity 99.1% (HPLC).

熔点:278-280℃; Melting point: 278-280°C;

核磁共振:1H NMR(500MHz,DMSO-d6)δ2.10(s,3H),2.40(s,3H),6.17(s,1H),7.15-7.19(m,2H),7.27-7.28(m,1H),7.38-7.51(m,3H),7.75(s,1H),8.66(s,1H); NMR: 1 H NMR (500MHz, DMSO-d 6 ) δ2.10(s, 3H), 2.40(s, 3H), 6.17(s, 1H), 7.15-7.19(m, 2H), 7.27-7.28( m, 1H), 7.38-7.51(m, 3H), 7.75(s, 1H), 8.66(s, 1H);

13C NMR(125MHz,DMSO-d6)δ20.5,22.3,63.9,118.6,123.9,124.4,124.9,126.2,127.5,127.7,129.9,132.8,136.1,138.9,140.7,152.4,162.2。 13 C NMR (125 MHz, DMSO-d 6 ) δ 20.5, 22.3, 63.9, 118.6, 123.9, 124.4, 124.9, 126.2, 127.5, 127.7, 129.9, 132.8, 136.1, 138.9, 140.7, 152.4, 162.2.

实施例3 Example 3

(A)化合物(II)的制备 (A) Preparation of compound (II)

在反应瓶中加入10mmol2-氨基-5-氯苯甲酰胺1、12mmol2-溴苯甲醛2、12mmol柠檬酸和10ml乙醇,于80℃下回流和搅拌下反应16小时。反应结束后,用无水MgSO4干燥,减压浓缩除去乙醇,残留物用400目硅胶柱层析色谱分离得目标产物(II),产率为82.5%。 Add 10mmol of 2-amino-5-chlorobenzamide 1, 12mmol of 2-bromobenzaldehyde 2, 12mmol of citric acid and 10ml of ethanol into the reaction flask, and react under reflux and stirring at 80°C for 16 hours. After the reaction was finished, it was dried with anhydrous MgSO 4 , concentrated under reduced pressure to remove ethanol, and the residue was separated by 400-mesh silica gel column chromatography to obtain the target product (II), with a yield of 82.5%.

(B)化合物(I)的制备 (B) Preparation of compound (I)

在装配有搅拌器、温度计、加料口的反应容器中,加入50ml溶剂二氯甲烷,然后加入上式化合物(II)、(III)、Cu(acac)2和Cs2CO3,使其摩尔比为1∶3∶0.08∶4,其中式(II)化合物为10mmol。氮气置换三次,然后在持续通入氮气的保护下,于90℃和搅拌下反应24小时。反应结束后,将混合物倾入乙酸乙酯中,顺次用饱和NaHCO3水溶液和盐水洗涤,在水层用乙酸乙酯萃取后,合并有机层(即合并洗涤后的有机层和萃取得到的有机层),用无水MgSO4干燥,负压蒸发除去溶剂,残留物通过快速柱色谱(正己烷/乙酸乙酯)提纯,得到上式 中的目标产物(I)。产率为98.5%,纯度为99.2%(HPLC)。 In a reaction vessel equipped with a stirrer, a thermometer, and a feeding port, add 50ml of solvent methylene chloride, then add compounds of the above formula (II), (III), Cu(acac) 2 and Cs 2 CO 3 to make the molar ratio It is 1:3:0.08:4, wherein the compound of formula (II) is 10 mmol. Nitrogen was replaced three times, and then reacted at 90° C. with stirring for 24 hours under the protection of continuous feeding of nitrogen. After the reaction was finished, the mixture was poured into ethyl acetate, washed with saturated NaHCO3 aqueous solution and brine successively, and after the aqueous layer was extracted with ethyl acetate, the organic layer was combined (that is, the organic layer after washing and the organic layer obtained by extraction were combined). layer), dried with anhydrous MgSO , evaporated under negative pressure to remove the solvent, and the residue was purified by flash column chromatography (n-hexane/ethyl acetate) to obtain the target product (I) in the above formula. Yield 98.5%, purity 99.2% (HPLC).

熔点:106-108℃。 Melting point: 106-108°C.

核磁共振:1H NMR(500MHz,DMSO-d6)δ2.12(s,3H),6.23(d,J=1.4Hz,1H),7.20-7.16(m,1H),7.23-7.21(m,1H),7.28-7.27(m,1H),7.41-7.37(m,1H),7.72-7.68(m,2H),7.88(d,J=1.3Hz,1H),8.89(s,1H); NMR: 1 H NMR (500MHz, DMSO-d 6 ) δ2.12(s, 3H), 6.23(d, J=1.4Hz, 1H), 7.20-7.16(m, 1H), 7.23-7.21(m, 1H), 7.28-7.27(m, 1H), 7.41-7.37(m, 1H), 7.72-7.68(m, 2H), 7.88(d, J=1.3Hz, 1H), 8.89(s, 1H);

13C NMR(125MHz,DMSO-d6)δ22.2,63.8,118.4,124.1,125.2,126.7,126.9,127.5,128.0,130.0,130.9,132.0,140.2,140.6,151.9,161.0。 13 C NMR (125 MHz, DMSO-d 6 ) δ 22.2, 63.8, 118.4, 124.1, 125.2, 126.7, 126.9, 127.5, 128.0, 130.0, 130.9, 132.0, 140.2, 140.6, 151.9, 161.0.

实施例4 Example 4

(A)化合物(II)的制备 (A) Preparation of compound (II)

在反应瓶中加入10mmol2-氨基-5-溴苯甲酰胺1、12mmol2-碘苯甲醛2、12mmol柠檬酸和10ml乙醇,于80℃下回流和搅拌下反应16小时。反应结束后,用无水MgSO4干燥,减压浓缩除去乙醇,残留物用400目硅胶柱层析色谱分离得目标产物(II),产率为83.7%。 Add 10mmol of 2-amino-5-bromobenzamide 1, 12mmol of 2-iodobenzaldehyde 2, 12mmol of citric acid and 10ml of ethanol into the reaction flask, and react under reflux and stirring at 80°C for 16 hours. After the reaction was finished, it was dried with anhydrous MgSO 4 , concentrated under reduced pressure to remove ethanol, and the residue was separated by 400-mesh silica gel column chromatography to obtain the target product (II), with a yield of 83.7%.

(B)化合物(I)的制备 (B) Preparation of compound (I)

在装配有搅拌器、温度计、加料口的反应容器中,加入50ml溶剂正己烷,然后加入上式化合物(II)、(III)、Cu(acac)2和Cs2CO3,使其摩尔比为1∶4∶0.12∶5,其中式(II)化合物为10mmol。氮气置换三次, 然后在持续通入氮气的保护下,于110℃和搅拌下反应27小时。反应结束后,将混合物倾入乙酸乙酯中,顺次用饱和NaHCO3水溶液和盐水洗涤,在水层用乙酸乙酯萃取后,合并有机层(即合并洗涤后的有机层和萃取得到的有机层),用无水Na2SO4干燥,负压蒸发除去溶剂,残留物通过快速柱色谱(正己烷/乙酸乙酯)提纯,得到上式中的目标产物(I)。产率为97.3%,纯度为98.7%(HPLC)。 In the reaction vessel equipped with stirrer, thermometer, feed port, add 50ml solvent n-hexane, then add above formula compound (II), (III), Cu(acac) 2 and Cs 2 CO 3 , make its molar ratio be 1:4:0.12:5, wherein the compound of formula (II) is 10 mmol. Nitrogen was replaced three times, and then reacted at 110° C. with stirring for 27 hours under the protection of continuous feeding of nitrogen. After the reaction was finished, the mixture was poured into ethyl acetate, washed with saturated NaHCO3 aqueous solution and brine successively, and after the aqueous layer was extracted with ethyl acetate, the organic layer was combined (that is, the organic layer after washing and the organic layer obtained by extraction were combined). layer), dried with anhydrous Na 2 SO 4 , evaporated under negative pressure to remove the solvent, and the residue was purified by flash column chromatography (n-hexane/ethyl acetate) to obtain the target product (I) in the above formula. Yield 97.3%, purity 98.7% (HPLC).

熔点:235-236℃。 Melting point: 235-236°C.

核磁共振:1H NMR(500MHz,DMSO-d6)δ2.12(s,3H),6.23(d,J=1.3Hz,1H),7.18-7.16(m,1H),7.23-7.19(m,1H),7.29-7.27(m,1H),7.40-7.37(m,1H),7.63-7.62(m,1H),7.84-7.82(m,1H),8.01(d,J=2.4Hz,1H),8.89(s,1H); NMR: 1 H NMR (500MHz, DMSO-d 6 ) δ2.12(s, 3H), 6.23(d, J=1.3Hz, 1H), 7.18-7.16(m, 1H), 7.23-7.19(m, 1H), 7.29-7.27(m, 1H), 7.40-7.37(m, 1H), 7.63-7.62(m, 1H), 7.84-7.82(m, 1H), 8.01(d, J=2.4Hz, 1H) , 8.89(s, 1H);

13C NMR(125MHz,DMSO-d6)δ22.3,63.8,118.4,119.0,124.1,125.2,127.0,127.5,128.3,129.9,130.0,134.9,140.5,141.6,151.8,160.9。 13 C NMR (125 MHz, DMSO-d 6 ) δ 22.3, 63.8, 118.4, 119.0, 124.1, 125.2, 127.0, 127.5, 128.3, 129.9, 130.0, 134.9, 140.5, 141.6, 151.8, 160.9.

实施例5 Example 5

(A)化合物(II)的制备 (A) Preparation of compound (II)

在反应瓶中加入10mmol邻氨基苯甲酰胺1、12mmol2-溴-5-氟苯甲醛2、12mmol柠檬酸和10ml乙醇,于80℃下回流和搅拌下反应20小时。反应结束后,用无水MgSO4干燥,减压浓缩除去乙醇,残留物用350目硅胶柱层析色谱分离得目标产物(II),产率为84.8%。 Add 10mmol anthranilamide 1, 12mmol 2-bromo-5-fluorobenzaldehyde 2, 12mmol citric acid and 10ml ethanol into the reaction flask, and react under reflux and stirring at 80°C for 20 hours. After the reaction was finished, it was dried with anhydrous MgSO 4 , concentrated under reduced pressure to remove ethanol, and the residue was separated by 350-mesh silica gel column chromatography to obtain the target product (II), with a yield of 84.8%.

(B)化合物(I)的制备 (B) Preparation of compound (I)

在装配有搅拌器、温度计、加料口的反应容器中,加入50ml溶剂甲醇,然后加入上式化合物(II)、(III)、Cu(acac)2和Cs2CO3,使其摩尔比为1∶1.5∶0.16∶6,其中式(II)化合物为10mmol。氮气置换三次,然后在持续通入氮气的保护下,于120℃和搅拌下反应30小时。反应结束后,将混合物倾入乙酸乙酯中,顺次用饱和NaHCO3水溶液和盐水洗涤,在水层用乙酸乙酯萃取后,合并有机层(即合并洗涤后的有机层和萃取得到的有机层),用无水Na2SO4干燥,负压蒸发除去溶剂,残留物通过快速柱色谱(正己烷/乙酸乙酯)提纯,得到上式中的目标产物(I)。产率为96.9%,纯度为98.6%(HPLC)。 In a reaction vessel equipped with a stirrer, a thermometer, and a feeding port, add 50ml of solvent methanol, then add compounds of the above formula (II), (III), Cu(acac) 2 and Cs 2 CO 3 so that the molar ratio is 1 : 1.5: 0.16: 6, wherein the compound of formula (II) is 10 mmol. Nitrogen was replaced three times, and then reacted at 120° C. with stirring for 30 hours under the protection of continuous feeding of nitrogen. After the reaction was finished, the mixture was poured into ethyl acetate, washed with saturated NaHCO3 aqueous solution and brine successively, and after the aqueous layer was extracted with ethyl acetate, the organic layer was combined (that is, the organic layer after washing and the organic layer obtained by extraction were combined). layer), dried with anhydrous Na 2 SO 4 , evaporated under negative pressure to remove the solvent, and the residue was purified by flash column chromatography (n-hexane/ethyl acetate) to obtain the target product (I) in the above formula. Yield 96.9%, purity 98.6% (HPLC).

熔点:217-218℃。 Melting point: 217-218°C.

核磁共振:1H NMR(500MHz,DMSO-d6)δ2.10(s,3H),6.22(s,1H),7.17-7.15(m,1H),7.25-7.19(m,2H),7.48-7.45(m,1H),7.67-7.62(m,2H),7.95(d,J=7.5Hz,1H),8.79(s,1H); NMR: 1 H NMR (500MHz, DMSO-d 6 ) δ2.10(s, 3H), 6.22(s, 1H), 7.17-7.15(m, 1H), 7.25-7.19(m, 2H), 7.48- 7.45(m, 1H), 7.67-7.62(m, 2H), 7.95(d, J=7.5Hz, 1H), 8.79(s, 1H);

13C NMR(125MHz,DMSO-d6)δ22.3,63.6,113.9,114.1,116.8,117.0,119.9,124.7,126.4,126.7,127.6,132.4,141.2,151.8,159.0,162.1。 13 C NMR (125 MHz, DMSO-d 6 ) δ 22.3, 63.6, 113.9, 114.1, 116.8, 117.0, 119.9, 124.7, 126.4, 126.7, 127.6, 132.4, 141.2, 151.8, 159.0, 162.1.

实施例6 Example 6

(A)化合物(II)的制备 (A) Preparation of compound (II)

在反应瓶中加入10mmol邻氨基苯甲酰胺1、12mmol2-溴-5-甲氧基苯甲醛2、12mmol柠檬酸和10ml乙醇,于80℃下回流和搅拌下反应16小时。反应结束后,用无水MgSO4干燥,减压浓缩除 去乙醇,残留物用300目硅胶柱层析色谱分离得目标产物(II),产率为85.1%。 Add 10mmol of anthranilamide 1, 12mmol of 2-bromo-5-methoxybenzaldehyde 2, 12mmol of citric acid and 10ml of ethanol into the reaction flask, and react under reflux and stirring at 80°C for 16 hours. After the reaction was finished, it was dried with anhydrous MgSO, concentrated under reduced pressure to remove ethanol, and the residue was separated by 300 mesh silica gel column chromatography to obtain the target product (II), with a yield of 85.1%.

(B)化合物(I)的制备 (B) Preparation of compound (I)

在装配有搅拌器、温度计、加料口的反应容器中,加入50ml溶剂1,6-二氧六环,然后加入上式化合物(II)、(III)、Cu(acac)2和Cs2CO3,使其摩尔比为1∶2.5∶0.2∶3,其中式(II)化合物为10mmol。氮气置换三次,然后在持续通入氮气的保护下,于70℃和搅拌下反应18小时。反应结束后,将混合物倾入乙酸乙酯中,顺次用饱和NaHCO3水溶液和盐水洗涤,在水层用乙酸乙酯萃取后,合并有机层(即合并洗涤后的有机层和萃取得到的有机层),用无水MgSO4干燥,负压蒸发除去溶剂,残留物通过快速柱色谱(正己烷/乙酸乙酯)提纯,得到上式中的目标产物(I)。产率为98.1%,纯度为98.9%(HPLC)。 In a reaction vessel equipped with a stirrer, a thermometer, and a feeding port, add 50ml of solvent 1,6-dioxane, and then add compounds of the above formula (II), (III), Cu(acac) 2 and Cs 2 CO 3 , so that the molar ratio is 1:2.5:0.2:3, wherein the compound of formula (II) is 10 mmol. Nitrogen was replaced three times, and then reacted at 70° C. with stirring for 18 hours under the protection of continuous feeding of nitrogen. After the reaction was finished, the mixture was poured into ethyl acetate, washed with saturated NaHCO3 aqueous solution and brine successively, and after the aqueous layer was extracted with ethyl acetate, the organic layer was combined (that is, the organic layer after washing and the organic layer obtained by extraction were combined). layer), dried with anhydrous MgSO4 , evaporated under negative pressure to remove the solvent, and the residue was purified by flash column chromatography (n-hexane/ethyl acetate) to obtain the target product (I) in the above formula. Yield 98.1%, purity 98.9% (HPLC).

熔点:264-266℃; Melting point: 264-266°C;

核磁共振1H NMR(500MHz,DMSO-d6)δ2.08(s,3H),3.76(s,3H),6.15(s,1H),6.88-6.87(m,1H),6.97-6.95(m,1H),7.12-7.11(m,1H),7.46-7.43(m,1H),7.65-7.60(m,2H),7.94(d,J=7.5Hz,1H),8.69(s,1H); Nuclear Magnetic Resonance 1 H NMR (500MHz, DMSO-d 6 ) δ2.08(s, 3H), 3.76(s, 3H), 6.15(s, 1H), 6.88-6.87(m, 1H), 6.97-6.95(m , 1H), 7.12-7.11(m, 1H), 7.46-7.43(m, 1H), 7.65-7.60(m, 2H), 7.94(d, J=7.5Hz, 1H), 8.69(s, 1H);

13C NMR(125MHz,DMSO-d6)δ22.2,55.4,64.1,112.1,115.9,119.4,124.7,125.3,126.3,126.4,127.6,132.3,134.3,141.5,150.0,156.6,162.2。 13 C NMR (125 MHz, DMSO-d 6 ) δ 22.2, 55.4, 64.1, 112.1, 115.9, 119.4, 124.7, 125.3, 126.3, 126.4, 127.6, 132.3, 134.3, 141.5, 150.0, 156.6, 162.2.

实施例7 Example 7

(A)化合物(II)的制备 (A) Preparation of compound (II)

在反应瓶中加入10mmol邻氨基苯甲酰胺1、12mmol2-碘-4-甲基苯甲醛2、12mmol柠檬酸和10ml乙醇,于80℃下回流和搅拌下反应12小时。反应结束后,用无水MgSO4干燥,减压浓缩除去乙醇,残留物用400目硅胶柱层析色谱分离得目标产物(II),产率为84.9%。 Add 10mmol of anthranilamide 1, 12mmol of 2-iodo-4-methylbenzaldehyde 2, 12mmol of citric acid and 10ml of ethanol into the reaction flask, and react under reflux and stirring at 80°C for 12 hours. After the reaction was finished, it was dried with anhydrous MgSO 4 , concentrated under reduced pressure to remove ethanol, and the residue was separated by 400-mesh silica gel column chromatography to obtain the target product (II), with a yield of 84.9%.

(B)化合物(I)的制备 (B) Preparation of compound (I)

在装配有搅拌器、温度计、加料口的反应容器中,加入50ml溶剂DMF,然后加入上式化合物(II)、(III)、Cu(acac)2和Cs2CO3,使其摩尔比为1∶3.5∶0.05∶2,其中式(II)化合物为10mmol。氮气置换三次然后在持续通入氮气的保护下,于80℃和搅拌下反应30小时。反应结束后,将混合物倾入乙酸乙酯中,顺次用饱和NaHCO3水溶液和盐水洗涤,在水层用乙酸乙酯萃取后,合并有机层(即合并洗涤后的有机层和萃取得到的有机层),用无水MgSO4干燥,负压蒸发除去溶剂,残留物通过快速柱色谱(正己烷/乙酸乙酯)提纯,得到上式中的目标产物(I)。产率为96.8%,纯度为99.5%(HPLC)。 In a reaction vessel equipped with a stirrer, a thermometer, and a feeding port, add 50ml of solvent DMF, and then add compounds of the above formula (II), (III), Cu(acac) 2 and Cs 2 CO 3 so that the molar ratio is 1 : 3.5: 0.05: 2, wherein the compound of formula (II) is 10 mmol. Nitrogen was replaced three times, and then reacted at 80° C. for 30 hours under the protection of continuous feeding of nitrogen. After the reaction was finished, the mixture was poured into ethyl acetate, washed with saturated NaHCO3 aqueous solution and brine successively, and after the aqueous layer was extracted with ethyl acetate, the organic layer was combined (that is, the organic layer after washing and the organic layer obtained by extraction were combined). layer), dried with anhydrous MgSO4 , evaporated under negative pressure to remove the solvent, and the residue was purified by flash column chromatography (n-hexane/ethyl acetate) to obtain the target product (I) in the above formula. Yield 96.8%, purity 99.5% (HPLC).

熔点:270-272℃; Melting point: 270-272°C;

核磁共振:1H NMR(500MHz,DMSO-d6)δ2.10(s,3H),3.32(s,3H),6.16(d,J=1.3Hz,1H),7.02-6.99(m,2H),7.16-7.15(m,1H),7.46-7.43(m,1H),7.65-7.60(m,2H),7.95-7.93(m,1H),8.64(s,1H); NMR: 1 H NMR (500MHz, DMSO-d 6 ) δ2.10(s, 3H), 3.32(s, 3H), 6.16(d, J=1.3Hz, 1H), 7.02-6.99(m, 2H) , 7.16-7.15(m, 1H), 7.46-7.43(m, 1H), 7.65-7.60(m, 2H), 7.95-7.93(m, 1H), 8.64(s, 1H);

13C NMR(125MHz,DMSO-d6)δ22.4,30.6,63.8,114.0,115.8,124.4,125.8,126.4,127.2,125.5,127.6,132.2,139.3,140.6,141.5, 152.0,162.1。 13 C NMR (125 MHz, DMSO-d 6 ) δ 22.4, 30.6, 63.8, 114.0, 115.8, 124.4, 125.8, 126.4, 127.2, 125.5, 127.6, 132.2, 139.3, 140.6, 141.5, 152.0, 162.1.

实施例8 Example 8

(A)化合物(II)的制备 (A) Preparation of compound (II)

在反应瓶中加入10mmol邻氨基苯甲酰胺1、12mmol2-溴-4,5-二甲氧基苯甲醛2、12mmol柠檬酸和10ml乙醇,于80℃下回流和搅拌下反应24小时。反应结束后,用无水MgSO4干燥,减压浓缩除去乙醇,残留物用350目硅胶柱层析色谱分离得目标产物(II),产率为85.0%。 Add 10mmol of anthranilamide 1, 12mmol of 2-bromo-4,5-dimethoxybenzaldehyde 2, 12mmol of citric acid and 10ml of ethanol into the reaction flask, and react under reflux and stirring at 80°C for 24 hours. After the reaction was finished, it was dried with anhydrous MgSO 4 , concentrated under reduced pressure to remove ethanol, and the residue was separated by 350-mesh silica gel column chromatography to obtain the target product (II), with a yield of 85.0%.

(B)化合物(I)的制备 (B) Preparation of compound (I)

在装配有搅拌器、温度计、加料口的反应容器中,加入50ml溶剂DMSO,然后加入上式化合物(II)、(III)、Cu(acac)2和Cs2CO3,使其摩尔比为1∶1∶0.1∶5,其中式(II)化合物为10mmol。氮气置换三次,然后在持续通入氮气的保护下,于90℃和搅拌下反应28小时。反应结束后,将混合物倾入乙酸乙酯中,顺次用饱和NaHCO3水溶液和盐水洗涤,在水层用乙酸乙酯萃取后,合并有机层(即合并洗涤后的有机层和萃取得到的有机层),用无水MgSO4干燥,负压蒸发除去溶剂,残留物通过快速柱色谱(正己烷/乙酸乙酯)提纯,得到上式中的目标产物(I)。产率为97.5%,纯度为99.0%(HPLC)。 In a reaction vessel equipped with a stirrer, a thermometer, and a feeding port, add 50ml of solvent DMSO, and then add compounds of the above formula (II), (III), Cu(acac) 2 and Cs 2 CO 3 so that the molar ratio is 1 : 1: 0.1: 5, wherein the compound of formula (II) is 10 mmol. Nitrogen was replaced three times, and then reacted at 90° C. with stirring for 28 hours under the protection of continuous feeding of nitrogen. After the reaction was finished, the mixture was poured into ethyl acetate, washed with saturated NaHCO3 aqueous solution and brine successively, and after the aqueous layer was extracted with ethyl acetate, the organic layer was combined (that is, the organic layer after washing and the organic layer obtained by extraction were combined). layer), dried with anhydrous MgSO4 , evaporated under negative pressure to remove the solvent, and the residue was purified by flash column chromatography (n-hexane/ethyl acetate) to obtain the target product (I) in the above formula. Yield 97.5%, purity 99.0% (HPLC).

熔点:270-272℃; Melting point: 270-272°C;

核磁共振:1H NMR(500MHz,DMSO-d6)δ2.09(s,3H),3.75(s,3H),3.78(s,3H),6.12(d,J=1.2Hz,1H),6.77(s,1H),6.88(s,1H),7.46-7.42(m,1H),7.64-7.61(m,2H),7.95-7.93(m,1H),8.62(s,1H); NMR: 1 H NMR (500MHz, DMSO-d 6 ) δ 2.09(s, 3H), 3.75(s, 3H), 3.78(s, 3H), 6.12(d, J=1.2Hz, 1H), 6.77 (s, 1H), 6.88 (s, 1H), 7.46-7.42 (m, 1H), 7.64-7.61 (m, 2H), 7.95-7.93 (m, 1H), 8.62 (s, 1H);

13C NMR(125MHz,DMSO-d6)δ22.2,55.5,55.8,64.1,107.6,110.0,110.4,124.7,126.2,126.4,127.5,128.8,132.2,141.5,146.4,149.9,150.2,162.1。 13 C NMR (125 MHz, DMSO-d 6 ) δ 22.2, 55.5, 55.8, 64.1, 107.6, 110.0, 110.4, 124.7, 126.2, 126.4, 127.5, 128.8, 132.2, 141.5, 146.4, 149.9, 150.2, 162.1.

实施例9 Example 9

在装配有搅拌器、温度计、加料口的反应容器中,加入50ml溶剂四氯化碳,然后加入上式化合物(II)、(III)、Cu(acac)2和Cs2CO3,使其摩尔比为1∶2∶0.2∶2,其中式(II)化合物为10mmol。氮气置换三次,然后在持续通入氮气的保护下,于100℃和搅拌下反应25小时。反应结束后,将混合物倾入乙酸乙酯中,顺次用饱和NaHCO3水溶液和盐水洗涤,在水层用乙酸乙酯萃取后,合并有机层(即合并洗涤后的有机层和萃取得到的有机层),用无水Na2SO4干燥,负压蒸发除去溶剂,残留物通过快速柱色谱(正己烷/乙酸乙酯)提纯,得到上式中的目标产物(I)。产率为97.1%,纯度为99.2%(HPLC)。 In a reaction vessel equipped with a stirrer, a thermometer, and a feeding port, add 50ml of solvent carbon tetrachloride, then add the above formula compound (II), (III), Cu(acac) 2 and Cs 2 CO 3 to make the mole The ratio is 1:2:0.2:2, wherein the compound of formula (II) is 10 mmol. Nitrogen was replaced three times, and then reacted at 100° C. with stirring for 25 hours under the protection of continuous feeding of nitrogen. After the reaction was finished, the mixture was poured into ethyl acetate, washed with saturated NaHCO3 aqueous solution and brine successively, and after the aqueous layer was extracted with ethyl acetate, the organic layer was combined (that is, the organic layer after washing and the organic layer obtained by extraction were combined). layer), dried with anhydrous Na 2 SO 4 , evaporated under negative pressure to remove the solvent, and the residue was purified by flash column chromatography (n-hexane/ethyl acetate) to obtain the target product (I) in the above formula. Yield 97.1%, purity 99.2% (HPLC).

熔点:243-245℃; Melting point: 243-245°C;

核磁共振:1H NMR(500MHz,DMSO-d6)δ0.94(t,J=7.4Hz,3H),2.24(dq,J=14.8Hz,7.4Hz,1H),2.40(s,3H),2.56(dq,J=14.8Hz,7.4Hz,1H),6.13(d,J=1.5Hz,1H),7.21-7.18(m,2H),7.28-7.26(m,1H),7.40-7.36(m,1H),7.45-7.43(m,1H),7.49-7.48(m,1H),7.76-7.75(m,1H),8.65(s,1H); NMR: 1 H NMR (500MHz, DMSO-d 6 ) δ0.94(t, J=7.4Hz, 3H), 2.24(dq, J=14.8Hz, 7.4Hz, 1H), 2.40(s, 3H), 2.56(dq, J=14.8Hz, 7.4Hz, 1H), 6.13(d, J=1.5Hz, 1H), 7.21-7.18(m, 2H), 7.28-7.26(m, 1H), 7.40-7.36(m , 1H), 7.45-7.43(m, 1H), 7.49-7.48(m, 1H), 7.76-7.75(m, 1H), 8.65(s, 1H);

13C NMR(125MHz,DMSO-d6)δ10.3,20.5,26.7,64.1,118.7,124.2,124.4,125.0,126.6,127.4,127.7,129.8,132.8,136.2,138.8,140.8,155.9,162.2。 13 C NMR (125 MHz, DMSO-d 6 ) δ 10.3, 20.5, 26.7, 64.1, 118.7, 124.2, 124.4, 125.0, 126.6, 127.4, 127.7, 129.8, 132.8, 136.2, 138.8, 140.8, 155.9, 162.2.

实施例10 Example 10

在装配有搅拌器、温度计、加料口的反应容器中,加入50ml溶剂正丁醇,然后加入上式化合物(II)、(III)、Cu(acac)2和Cs2CO3,使其摩尔比为1∶1.2∶0.05∶2.5,其中式(II)化合物为10mmol。氮气置换三次,然后在持续通入氮气的保护下,于90℃和搅拌下反应20小时。反应结束后,将混合物倾入乙酸乙酯中,顺次用饱和NaHCO3水溶液和盐水洗涤,在水层用乙酸乙酯萃取后,合并有机层(即合并洗涤后的有机层和萃取得到的有机层),用无水MgSO4干燥,负压蒸发除去溶剂,残留物通过快速柱色谱(正己烷/乙酸乙酯)提纯,得到上式中的目标产物(I)。产率为96.8%,纯度为98.4%(HPLC)。 In a reaction vessel equipped with a stirrer, a thermometer, and a feeding port, add 50ml of solvent n-butanol, and then add compounds of the above formula (II), (III), Cu(acac) 2 and Cs 2 CO 3 to make the molar ratio It is 1:1.2:0.05:2.5, wherein the compound of formula (II) is 10 mmol. Nitrogen was replaced three times, and then reacted at 90° C. with stirring for 20 hours under the protection of continuous feeding of nitrogen. After the reaction was finished, the mixture was poured into ethyl acetate, washed with saturated NaHCO3 aqueous solution and brine successively, and after the aqueous layer was extracted with ethyl acetate, the organic layer was combined (that is, the organic layer after washing and the organic layer obtained by extraction were combined). layer), dried with anhydrous MgSO4 , evaporated under negative pressure to remove the solvent, and the residue was purified by flash column chromatography (n-hexane/ethyl acetate) to obtain the target product (I) in the above formula. Yield 96.8%, purity 98.4% (HPLC).

熔点:175-176℃; Melting point: 175-176°C;

核磁共振:1H NMR(500MHz,DMSO-d6)δ0.92(t,J=7.4Hz,3H),2.22(dq,J=14.8Hz,7.4Hz,1H),2.57(dq,J=14.8Hz,7.4Hz,1H),3.76(s,3H),6.12(d,J=1.4Hz,1H),6.88-6.87(m,1H),6.98-6.95(m,1H),7.15-7.14(m,1H),7.47-7.43(m,1H),7.65-7.59(m,2H),7.95-7.94(m,1H),8.67(s,1H); NMR: 1 H NMR (500MHz, DMSO-d 6 ) δ0.92(t, J=7.4Hz, 3H), 2.22(dq, J=14.8Hz, 7.4Hz, 1H), 2.57(dq, J=14.8 Hz, 7.4Hz, 1H), 3.76(s, 3H), 6.12(d, J=1.4Hz, 1H), 6.88-6.87(m, 1H), 6.98-6.95(m, 1H), 7.15-7.14(m , 1H), 7.47-7.43(m, 1H), 7.65-7.59(m, 2H), 7.95-7.94(m, 1H), 8.67(s, 1H);

13C NMR(125MHz,DMSO-d6)δ10.3,26.7,55.4,64.3,112.7,115.8,119.5,124.7,125.5,126.5,126.7,127.5,132.2,134.3,141.4,153.5,156.6,162.2。 13 C NMR (125 MHz, DMSO-d 6 ) δ 10.3, 26.7, 55.4, 64.3, 112.7, 115.8, 119.5, 124.7, 125.5, 126.5, 126.7, 127.5, 132.2, 134.3, 141.4, 153.5, 156.6, 162.2.

实施例11 Example 11

在装配有搅拌器、温度计、加料口的反应容器中,加入50ml溶剂乙醚,然后加入上式化合物(II)、(III)、Cu(acac)2和Cs2CO3,使其摩尔比为1∶2∶0.15∶4.5,其中式(II)化合物为10mmol。氮气置换三次,然后在持续通入氮气的保护下,于80℃和搅拌下反应28小时。反应结束后,将混合物倾入乙酸乙酯中,顺次用饱和NaHCO3水溶液和盐水洗涤,在水层用乙酸乙酯萃取后,合并有机层(即合并洗涤后的有机层和萃取得到的有机层),用无水MgSO4干燥,负压蒸发除去溶剂,残留物通过快速柱色谱(正己烷/乙酸乙酯)提纯,得到上式中的目标产物(I)。产率为96.9%,纯度为98.9%(HPLC)。 In a reaction vessel equipped with a stirrer, a thermometer, and a feeding port, add 50ml of solvent diethyl ether, and then add compounds of the above formula (II), (III), Cu(acac) 2 and Cs 2 CO 3 so that the molar ratio is 1 : 2: 0.15: 4.5, wherein the compound of formula (II) is 10 mmol. Nitrogen was replaced three times, and then reacted at 80° C. with stirring for 28 hours under the protection of continuous feeding of nitrogen. After the reaction was finished, the mixture was poured into ethyl acetate, washed with saturated NaHCO3 aqueous solution and brine successively, and after the aqueous layer was extracted with ethyl acetate, the organic layer was combined (that is, the organic layer after washing and the organic layer obtained by extraction were combined). layer), dried with anhydrous MgSO4 , evaporated under negative pressure to remove the solvent, and the residue was purified by flash column chromatography (n-hexane/ethyl acetate) to obtain the target product (I) in the above formula. Yield 96.9%, purity 98.9% (HPLC).

熔点:215-217℃; Melting point: 215-217°C;

核磁共振:1H NMR(500MHz,DMSO-d6)δ0.71-0.65(m,1H),0.98-0.91(m,2H)1.22-1.17(m,1H),1.59-1.54(m,1H),6.24(d,J=1.5Hz,1H),7.09-7.07(m,1H),7.17-7.14(m,1H),7.27-7.26(m,1H),7.36-7.33(m,1H),7.48-7.45(m,1H),7.67-7.62(m,2H),7.98-7.96(m,1H),8.78(s,1H); NMR: 1 H NMR (500MHz, DMSO-d 6 ) δ0.71-0.65(m, 1H), 0.98-0.91(m, 2H), 1.22-1.17(m, 1H), 1.59-1.54(m, 1H) , 6.24(d, J=1.5Hz, 1H), 7.09-7.07(m, 1H), 7.17-7.14(m, 1H), 7.27-7.26(m, 1H), 7.36-7.33(m, 1H), 7.48 -7.45(m, 1H), 7.67-7.62(m, 2H), 7.98-7.96(m, 1H), 8.78(s, 1H);

13C NMR(125MHz,DMSO-d6)δ7.3,10.6,12.9,64.3,118.3,124.1,124.7,124.8,126.5,126.7,127.5,127.8,129.9,132.1,140.7,141.2,155.3,162.3。 13 C NMR (125 MHz, DMSO-d 6 ) δ7.3, 10.6, 12.9, 64.3, 118.3, 124.1, 124.7, 124.8, 126.5, 126.7, 127.5, 127.8, 129.9, 132.1, 140.7, 141.2, 155.3, 162.3.

实施例12 Example 12

在装配有搅拌器、温度计、加料口的反应容器中,加入50ml溶剂丙酮,然后加入上式化合物(II)、(III)、Cu(acac)2和Cs2CO3,使其摩尔比为1∶1.2∶0.2∶2,其中式(II)化合物为10mmol。氮气置换三次,然后在持续通入氮气的保护下,于70℃和搅拌下反应17小时。反应结束后,将混合物倾入乙酸乙酯中,顺次用饱和NaHCO3水溶液和盐水洗涤,在水层用乙酸乙酯萃取后,合并有机层(即合并洗涤后的有机层和萃取得到的有机层),用无水MgSO4干燥,负压蒸发除去溶剂,残留物通过快速柱色谱(正己烷/乙酸乙酯)提纯,得到上式中的目标产物(I)。产率为96.3%,纯度为99.4%(HPLC)。 In the reaction vessel equipped with stirrer, thermometer, feeding port, add 50ml of solvent acetone, then add above formula compound (II), (III), Cu(acac) 2 and Cs 2 CO 3 , make its molar ratio be 1 : 1.2: 0.2: 2, wherein the compound of formula (II) is 10 mmol. Nitrogen was replaced three times, and then reacted at 70° C. with stirring for 17 hours under the protection of continuous feeding of nitrogen. After the reaction was finished, the mixture was poured into ethyl acetate, washed with saturated NaHCO3 aqueous solution and brine successively, and after the aqueous layer was extracted with ethyl acetate, the organic layer was combined (that is, the organic layer after washing and the organic layer obtained by extraction were combined). layer), dried with anhydrous MgSO4 , evaporated under negative pressure to remove the solvent, and the residue was purified by flash column chromatography (n-hexane/ethyl acetate) to obtain the target product (I) in the above formula. Yield 96.3%, purity 99.4% (HPLC).

熔点:214-216℃; Melting point: 214-216°C;

核磁共振:1H NMR(500MHz,DMSO-d6)δ0.67-0.61(m,1H),0.95-0.85(m,2H)1.16-1.11(m,1H),1.56-1.51(m,1H),3.75(s,3H),6.18(d,J=1.5Hz,1H),6.87-6.86(m,1H),6.94-6.92(m,1H),7.05-7.03(m,1H),7.47-7.43(m,1H),7.67-7.62(m,2H),7.98-7.96(m,1H),8.71(s,1H); NMR: 1 H NMR (500MHz, DMSO-d 6 ) δ0.67-0.61(m, 1H), 0.95-0.85(m, 2H), 1.16-1.11(m, 1H), 1.56-1.51(m, 1H) , 3.75(s, 3H), 6.18(d, J=1.5Hz, 1H), 6.87-6.86(m, 1H), 6.94-6.92(m, 1H), 7.05-7.03(m, 1H), 7.47-7.43 (m, 1H), 7.67-7.62(m, 2H), 7.98-7.96(m, 1H), 8.71(s, 1H);

13C NMR(125MHz,DMSO-d6)δ7.0,10.3,12.9,55.3,64.5,112.09,115.8,119.0,124.8,125.3,126.3,126.5,127.7,132.1,134.3,141.3,153.1,156.3,162.4。 13 C NMR (125MHz, DMSO-d 6 ) δ7.0, 10.3, 12.9, 55.3, 64.5, 112.09, 115.8, 119.0, 124.8, 125.3, 126.3, 126.5, 127.7, 132.1, 134.3, 141.3, 153.1, 156.4, 16 .

实施例13 Example 13

装配有搅拌器、温度计、加料口的反应容器中,加入50ml溶剂氯苯,然后加入上式化合物(II)、(III)、Cu(acac)2和Cs2CO3,使其摩尔比为1∶3.8∶0.04∶3.7,其中式(II)化合物为10mmol。氮气置换三次,然后在持续通入氮气的保护下,于60℃和搅拌下反应30小时。反应结束后,将混合物倾入乙酸乙酯中,顺次用饱和NaHCO3水溶液和盐水洗涤,在水层用乙酸乙酯萃取后,合并有机层(即合并洗涤后的有机层和萃取得到的有机层),用无水MgSO4干燥,负压蒸发除去溶剂,残留物通过快速柱色谱(正己烷/乙酸乙酯)提纯,得到上式中的目标产物(I)。产率为94.1%,纯度为98.5%(HPLC)。 In the reaction vessel equipped with stirrer, thermometer, feeding port, add 50ml solvent chlorobenzene, then add above formula compound (II), (III), Cu(acac) 2 and Cs 2 CO 3 , make its molar ratio be 1 : 3.8: 0.04: 3.7, wherein the compound of formula (II) is 10 mmol. Nitrogen was replaced three times, and then reacted at 60° C. with stirring for 30 hours under the protection of continuous feeding of nitrogen. After the reaction was finished, the mixture was poured into ethyl acetate, washed with saturated NaHCO3 aqueous solution and brine successively, and after the aqueous layer was extracted with ethyl acetate, the organic layer was combined (that is, the organic layer after washing and the organic layer obtained by extraction were combined). layer), dried with anhydrous MgSO4 , evaporated under negative pressure to remove the solvent, and the residue was purified by flash column chromatography (n-hexane/ethyl acetate) to obtain the target product (I) in the above formula. Yield 94.1%, purity 98.5% (HPLC).

熔点:232-233℃; Melting point: 232-233°C;

核磁共振:1H NMR(500MHz,DMSO-d6)δ0.73(d,J=6.8Hz,3H),1.24(d,J=6.6Hz,3H),3.01-2.93(m,1H),6.17(d,J=1.6Hz,1H),7.20-7.18(m,2H),7.28-7.26(m,1H),7.40-7.37(m,1H),7.49-7.46(m,1H),7.56-7.55(m,1H),7.67-7.63(m,1H),7.96-7.95(m,1H),8.77(s,1H); NMR: 1 H NMR (500MHz, DMSO-d 6 ) δ0.73 (d, J=6.8Hz, 3H), 1.24 (d, J=6.6Hz, 3H), 3.01-2.93 (m, 1H), 6.17 (d, J=1.6Hz, 1H), 7.20-7.18(m, 2H), 7.28-7.26(m, 1H), 7.40-7.37(m, 1H), 7.49-7.46(m, 1H), 7.56-7.55 (m, 1H), 7.67-7.63(m, 1H), 7.96-7.95(m, 1H), 8.77(s, 1H);

13C NMR(125MHz,DMSO-d6)δ19.8,20.2,29.2,64.2,118.4,124.3,124.6,125.1,126.7,127.2,127.5,127.6,129.9,132.2,140.7,141.2,159.1,162.3。 13 C NMR (125 MHz, DMSO-d 6 ) δ 19.8, 20.2, 29.2, 64.2, 118.4, 124.3, 124.6, 125.1, 126.7, 127.2, 127.5, 127.6, 129.9, 132.2, 140.7, 141.2, 159.1, 162.3.

由上述实施例1-13可看出,当采用本发明的所述方法时,能够以高产率、高纯度得到喹唑啉并喹唑啉酮化合物。 It can be seen from the above Examples 1-13 that when the method of the present invention is adopted, quinazolinoquinazolinone compounds can be obtained with high yield and high purity.

实施例14-26 Examples 14-26

除将其中的Cu(acac)2替换为如下的铜化合物外,以与实施例1-13相同的方式而分别实施了实施例14-26,其铜源催化剂、实施例对应关系和相应产物的收率如下表所示。 Except that Cu(acac) therein is replaced by following copper compound, implemented respectively embodiment 14-26 in the same manner as embodiment 1-13, its copper source catalyst, embodiment corresponding relation and corresponding product The yields are shown in the table below.

由上表可看出,当使用其它铜源催化剂时,一样能够得到相应的产率,但产物收率要显著低于使用Cu(acac)2为催化剂时的收率。 As can be seen from the above table, when other copper source catalysts are used, corresponding yields can be obtained, but the product yield is significantly lower than that of using Cu(acac) as the catalyst.

实施例27-39 Examples 27-39

除将其中的碳酸铯替换为如下的有机碱或无机碱外,分别以与实施例1-12相同的方式而分别实施了实施例27-39,所用碱、实施例对应关系和相应产物的收率如下表所示。 Except that the cesium carbonate wherein is replaced by following organic base or inorganic base, implement embodiment 27-39 respectively in the same manner as embodiment 1-12 respectively, the corresponding relationship of used base, embodiment and the collection of corresponding product The rates are shown in the table below.

*:DABCO为1,4-二氮杂二环[2.2.2]辛烷 *: DABCO is 1,4-diazabicyclo[2.2.2]octane

NR:未反应。  NR: No reaction. the

由上表可看出,出乎意外地,当使用除碳酸铯外的其它碱包括有机碱时,产物的产率大幅度降低,甚至完全不发生反应。同时可看出,即便是使用同为铯盐的硫酸铯,反应也几乎不能进行[见实施例36]。这证明了碳酸铯对该反应具有特定的专一性。 As can be seen from the above table, unexpectedly, when other bases including organic bases except cesium carbonate are used, the yield of the product is greatly reduced, or even no reaction occurs at all. At the same time, it can be seen that even if cesium sulfate, which is also a cesium salt, is used, the reaction can hardly proceed [see Example 36]. This demonstrates the specific specificity of cesium carbonate for this reaction.

荧光测试效果  Fluorescence test effect

将本发明实施例13所得的喹唑啉并喹唑啉酮化合物(标记为13I)分别浸入摩尔浓度均为0.1mol/L的Ni(NO3)2、Co(NO3)2和Fe(NO3)3水溶液中,浸泡20分钟后,抽滤,并在80℃的烘箱中干燥1小时,连同未处理的实施例13所得喹唑啉并喹唑啉酮化合物分别命名为13I、13I+Ni2+、13I+Co2+和13I+Fe3+The quinazolinoquinazolinone compound (marked as 13I) obtained in Example 13 of the present invention was respectively immersed in Ni(NO 3 ) 2 , Co(NO 3 ) 2 and Fe(NO 3 ) 2 with a molar concentration of 0.1 mol/L. 3 ) In the aqueous solution of 3 , after soaking for 20 minutes, suction filtration, and drying in an oven at 80°C for 1 hour, together with the untreated quinazolinoquinazolinone compounds obtained in Example 13, were named 13I, 13I+Ni 2+ , 13I+Co 2+ and 13I+Fe 3+ .

采用岛津RF-5301PC荧光分光光度计在不同长波长测量上述四个样品的固体荧光,结果见附图1。 The solid fluorescence of the above four samples was measured at different long wavelengths with a Shimadzu RF-5301PC fluorescence spectrophotometer, and the results are shown in Figure 1.

由图1可以明确看出,在400-500nm波长范围内,本发明喹唑啉并喹唑啉酮化合物与金属离子的荧光强度有着显著的改变,尤其是在425nm附近,其荧光强度与13I的的荧光强度变化最大,特别的针对13I+Fe3+而言,其荧光强度仅为13I的50%左右,如此意味着其可用于荧光淬灭、Fe离子检测等具体应用中,由于其与Fe3+产生了优异的荧光淬灭性能,可适用作诸如Fe3+的荧光探针等具体应用。因此,基于如此强的荧光强度差异,可将本发明的喹唑啉并喹唑啉酮化合物用于多种具体的荧光传感领域,如金属离子识别、显示、检测、荧光淬灭等等,尤其是用作Fe3+的荧光探针,在工业应用上具有良好的应用前景和研究价值。 As can be clearly seen from Fig. 1, within the wavelength range of 400-500nm, the fluorescence intensity of the quinazolinoquinazolinone compound of the present invention and the metal ion has a significant change, especially near 425nm, its fluorescence intensity is the same as that of 13I The fluorescence intensity of 13I has the largest change, especially for 13I+Fe 3+ , its fluorescence intensity is only about 50% of 13I, which means that it can be used in specific applications such as fluorescence quenching and Fe ion detection, because it is compatible with Fe 3+ produces excellent fluorescence quenching performance, which can be used as a fluorescent probe for Fe 3+ and other specific applications. Therefore, based on such a strong fluorescence intensity difference, the quinazoline and quinazolinone compounds of the present invention can be used in various specific fluorescent sensing fields, such as metal ion recognition, display, detection, fluorescence quenching, etc., Especially as a fluorescent probe for Fe 3+ , it has good application prospects and research value in industrial applications.

当使用实施例13之外的其它实施例,即实施例1-12所得的喹唑啉并喹唑啉酮化合物与Ni2+、Co2+和Fe3+进行同样测量时,与附图 1有着高度类似的荧光改变特性,同样意味着这些化合物也可用于荧光传感领域等。 When using other embodiments except embodiment 13, i.e. the quinazoline and quinazolinone compound obtained in embodiment 1-12 and Ni 2+ , Co 2+ and Fe 3+ to carry out the same measurement, with accompanying drawing 1 Having highly similar fluorescence changing characteristics also means that these compounds can also be used in the field of fluorescence sensing, etc.

综上所述,由上述所有实施例可明确看出,当采用本发明的方法时,不但能够顺利实现对二氢喹唑啉酮与脒化合物的反应,而且能够以高收率和高纯度得到目的产物,是一种非常有工业应用前景的全新合成方法,为喹唑啉并喹唑啉酮类化合物的高效快捷合成提供了全新的合成路线。此外,还发现了本发明所述喹唑啉并喹唑啉酮类化合物的用于荧光传感领域的新用途,为其应用领域的拓展提供了理论基础和探索性研究。 In summary, it can be clearly seen from all the above examples that when the method of the present invention is adopted, not only can the reaction of dihydroquinazolinone and amidine compound be successfully realized, but also can be obtained with high yield and high purity. The target product is a brand-new synthetic method with great industrial application prospects, and provides a brand-new synthetic route for the efficient and rapid synthesis of quinazolinoquinazolinone compounds. In addition, a new application of the quinazolinoquinazolinone compound in the present invention in the field of fluorescence sensing has also been discovered, which provides a theoretical basis and exploratory research for the expansion of its application field.

应当理解,这些实施例的用途仅用于说明本发明而非意欲限制本发明的保护范围。此外,也应理解,在阅读了本发明的技术内容之后,本领域技术人员可以对本发明作各种改动、修改和/或变型,所有的这些等价形式同样落于本申请所附权利要求书所限定的保护范围之内。 It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the protection scope of the present invention. In addition, it should also be understood that after reading the technical content of the present invention, those skilled in the art can make various changes, modifications and/or variations to the present invention, and all these equivalent forms also fall within the appended claims of the present application. within the defined scope of protection.

Claims (9)

1. a quinazo quinazolinones, its structural formula is as shown in the formula shown in (I):
Wherein:
R 1-R 4identical or different separately, and independently selected from H, C 1-C 6alkyl, halogen, C 1-C 6alkoxyl group;
R is selected from C 1-C 6alkyl, C 1-C 6alkoxyl group, C 3-C 6cycloalkyl;
Condition is when R is methyl, R 1-R 4be asynchronously H.
2. quinazo quinazolinones as claimed in claim 1, is characterized in that: R is C 2-C 6alkyl or C 3-C 6cycloalkyl.
3. quinazo quinazolinones as claimed in claim 2, is characterized in that: R is ethyl or cyclopropyl.
4. the quinazo quinazolinones as described in any one of claim 1-3, is characterized in that: R 4for H.
5. the synthetic method of quinazo quinazolinones as claimed in claim 1, it is characterized in that: described method makes formula (II) and (III) react and obtain formula (I) compound under being included in copper source catalyzer and alkali existence in organic solvent.
Wherein, R 1-R 4, R definition as described in the appended claim 1;
X is halogen;
Described copper source catalyzer is CuI, CuBr, CuCl, CuCl 2, CuBr 2, CuI 2in any one or multiple; Or be venus crystals, Cu (acac) 2, Cu (PPh 3) 2nO 3, ethyl acetoacetic acid copper (II), in hexafluoroacetylacetone copper any one or multiple;
Described alkali be in salt of wormwood, potassiumphosphate, Quilonum Retard, lithium hydroxide, cesium carbonate any one or multiple.
6. synthetic method as claimed in claim 5, is characterized in that: described formula (II) is 1: 1-4 with the mol ratio of (III) compound; The mol ratio of described formula (II) compound and copper source catalyzer is 1: 0.02-0.2; The mol ratio of described formula (II) compound and alkali is 1: 2-6.
7. the synthetic method as described in claim 5 or 6, is characterized in that: described copper source catalyzer is Cu (acac) 2, described alkali is cesium carbonate.
8. the synthetic method as described in claim 5 or 6, is characterized in that: temperature of reaction is 60-120 DEG C, and the reaction times is 16-30 hour.
9. the quinazo quinazolinones as described in any one of claim 1-4 is used for the purposes in fluorescence sense field.
CN201310224222.7A 2013-05-30 2013-05-30 Quinazoline and quinazolinone compound, its synthesis method and application Expired - Fee Related CN103275085B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310224222.7A CN103275085B (en) 2013-05-30 2013-05-30 Quinazoline and quinazolinone compound, its synthesis method and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310224222.7A CN103275085B (en) 2013-05-30 2013-05-30 Quinazoline and quinazolinone compound, its synthesis method and application

Publications (2)

Publication Number Publication Date
CN103275085A CN103275085A (en) 2013-09-04
CN103275085B true CN103275085B (en) 2015-04-08

Family

ID=49057729

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310224222.7A Expired - Fee Related CN103275085B (en) 2013-05-30 2013-05-30 Quinazoline and quinazolinone compound, its synthesis method and application

Country Status (1)

Country Link
CN (1) CN103275085B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103664963B (en) * 2013-12-23 2015-07-01 温州大学 Method for synthesizing quinazolino indazole derivatives
CN105017262B (en) * 2015-07-07 2017-05-03 广东也乐新材料制造有限公司 Synthetic method of aldehyde multi-substituted heterocyclic aromatic hydrocarbon compound

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62192369A (en) * 1986-02-19 1987-08-22 Nippon Keikou Kagaku Kk Fluorescent quinazolone derivative composition and production thereof
CN1252800A (en) * 1997-04-25 2000-05-10 詹森药业有限公司 Farnesyltransferase inhibiting quinazolinones

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100933498B1 (en) * 2008-12-12 2009-12-23 신상규 Separation and Purification Method of Cunazolinone-based Fluorescent Materials
US8697714B2 (en) * 2010-07-28 2014-04-15 Nanyang Technological University Quinazolinone based fluorogenic probes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62192369A (en) * 1986-02-19 1987-08-22 Nippon Keikou Kagaku Kk Fluorescent quinazolone derivative composition and production thereof
CN1252800A (en) * 1997-04-25 2000-05-10 詹森药业有限公司 Farnesyltransferase inhibiting quinazolinones

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Cyclisation of 2-(2-aminophenyl)quinazolin-4(3H)-one reexamined:formation of isomeric angular fused quinazolinoquinazolinones and their spectroscopic identification;Somepalli V.等;《Tetrahedron Letters》;20121231;第53卷;第2643-2646页 *
Synthesis of isomeric angularly fused dihydroquinazolinoquinazolinones and an unusual oxidative rearrangement;Somepalli Venkateswarlu等;《Tetrahedron Letters》;20121101;第54卷;第128-131页 *

Also Published As

Publication number Publication date
CN103275085A (en) 2013-09-04

Similar Documents

Publication Publication Date Title
JP5587324B2 (en) Preparation of quinolinyloxydiphenylcyclopropanedicarboxamide
CN103467388B (en) Method for synthesizing aryl or heteroaryl substituted quinazoline compound
CN106674136B (en) Pyrimidine antitumor compound and preparation method thereof
CN103435558B (en) Synthetic method of quinazoline derivative
CN104529895B (en) Synthetic method of replacing nitrogen-containing heterocyclic compound
CN105348168A (en) 1-(2-(adamantane-1-yl)-1H-indole-5-yl)-3-substituted urea derivative, preparation and use thereof
CN103275085B (en) Quinazoline and quinazolinone compound, its synthesis method and application
CN103601645B (en) The preparation method of 1-(phenethyl amino) propane-2-alcohol compound or its salt
CN102120734A (en) Method for preparing 2-(N-alkyl)aminobenzothiazole derivatives by using active alcohol as alkylating reagent
CN103275017B (en) 2-substituted quinazolinone compound, its synthesis method and application
CN102180844B (en) Gefitinib intermediate and preparation method of Gefitinib
CN102659629B (en) Compound and application thereof in preparing erlotinib
CN101195626A (en) Method for synthesizing pyrazolo [3, 4-d ] pyrimidine-4 (5H) -ketone compound
CN103275086B (en) 6-substituted quinazoline and quinazolinone compound, its synthesis method and application
CN104557701A (en) Preparation method of isoquinoline derivative
CN103224498B (en) Two kinds of azoles the novel synthesis of quinazolinone fused heterocycle
CN105777616B (en) Synthetic intermediate of Ceritinib and preparation method thereof
CN104592222A (en) Preparation method for antiplatelet medicine AZD6482
Wu et al. Synthesis of 4‐Aryl‐3‐Methyl‐1‐Phenyl‐1H‐Benzo [h] Pyrazolo [3, 4‐b] Quinoline‐5, 10‐diones Using Diammonium Hydrogen Phosphate as an Efficient and Versatile Catalyst in Water
Bu et al. NEW AND CONVERGENT SYNTHESIS OF AZD 4547
WO2019076316A1 (en) Preparation method for tyrosine kinase inhibitor and intermediate thereof
CN108358903A (en) The synthetic method of 2- substituted heterocycle quianzolinones
CN102050766A (en) Synthesis method for amosulalol hydrochloride
Wang et al. Facile Synthesis of Novel N4-Substituted 2-(Trifluoromethyl)-tetrahydrobenzothieno [2, 3-d] pyrimidine Derivatives
CN119409630A (en) Asymmetric polyfluorinated substituted 2,4′-biquinoline-4-amide derivative and preparation method and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150408